Caspofungin

CAS 162808-62-0 0 current records 2 historicalSmall Molecule

Who holds supplier records for Caspofungin? No organisation holds a current US Type II DMF or EU CEP for Caspofungin in the registers PharmaTek covers. A further 2 organisations have only historical (inactive) DMF filings.

Most records are filed under another form of this substance: Caspofungin Acetate (9 current sources). A DMF or CEP is listed under the form it names.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Caspofungin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/caspofungin

Reading the evidence

  • No current DMF or CEP on record

    Only historical filings exist in the covered registers. Any of these organisations may or may not supply today; confirm directly.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Caspofungin expires 21 Dec 2032. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (0)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Caspofungin. Country is the organisation's recorded country, not necessarily the manufacturing site.

Not found in the covered registers (FDA DMF list, EDQM). This is not evidence that no supplier exists.

Need Caspofungin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (2)

Organisations whose Type II DMFs for Caspofungin are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • Denmark · Inactive DMF 27156 · filed Jun 2013
  • Teva Pharmaceutical Industries Ltd.
    Israel · Inactive DMF 22770 · filed May 2009

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (8 listed products contain Caspofungin). The latest listed patent expires 21 Dec 2032. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Caspofungin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1630575).

Chemical identity

IUPAC name
(10R,12S)-N-[(3S,6S,9S,11R,15S,18S,20R,21S,24S,25S)-21-(2-aminoethylamino)-3-[(1R)-3-amino-1-hydroxypropyl]-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]-10,12-dimethyltetradecanamide
Canonical SMILES
CC[C@H](C)C[C@H](C)CCCCCCCCC(=O)N[C@H]1C[C@H]([C@H](NC(=O)[C@@H]2[C@H](CCN2C(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@@H](NC1=O)[C@@H](C)O)O)[C@@H]([C@H](C4=CC=C(C=C4)O)O)O)[C@@H](CCN)O)O)NCCN)O
InChIKey
JYIKNQVWKBUSNH-WVDDFWQHSA-N
Synonyms
Caspofungin, Caspofungina, Caspofungine, L-743,872, L-743872, L 743872, caspofunginum, CHEBI:474180, RefChem:56792, J02AX04, L743872, L743,872

Record history

No change to the current records between 11 Nov 2026 and 12 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

What do the historical Caspofungin records mean?

2 organisations have only inactive Type II DMFs for Caspofungin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does the FDA Orange Book list patents for products containing Caspofungin?

Yes. The latest patent listed for an approved US product containing Caspofungin expires 21 Dec 2032, across 8 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Caspofungin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Caspofungin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.